Skip to main content
Screener/Healthcare/Biotechnology

APLS — Apellis Pharmaceuticals, Inc.

NASDAQ
$41.02+0.01 (+0.04%)
Mid CapUnder $50HealthcareHigh ROE
$16.10
$41.14
$41.00
$41.05
EPS (TTM)$0.91
P/E Ratio45.08
Dividend Yield—
Market Cap$5.24B
Volume3.69M
Prev Close$41.01
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$192.0M$18.7M$0.0078.9%9.7%
Q4 '25$199.9M-$59.0M$-0.4785.1%-29.5%
Q3 '25$458.6M$215.7M$1.7194.7%47.0%
Q2 '25$178.5M-$42.2M$-0.3392.1%-23.6%
Q1 '25$166.8M-$92.2M$-0.7479.4%-55.3%
Q4 '24$212.5M-$36.4M$-0.2980.8%-17.1%
Q3 '24$196.8M-$57.4M$-0.4683.0%-29.2%
Q2 '24$199.7M-$37.7M$-0.3088.2%-18.9%
Get Your Daily Market Recap